Larvol Delta - Biosion-Announces-First-Patient-Dosed-in-InvestigatorInitiated-Phase-1-Trial-of-BSI082-a-NextGeneration-AntiSIRP-Monoclonal-Antibody-for-Advanced-Solid-Tumors

BSI-082 - Biosion

https://www.prnewswire.com/news-releases/biosion-announces-first-patient-dosed-in-investigator-initiated-phase-1-trial-of-bsi-082-a-next-generation-anti-sirp-monoclonal-antibody-for-advanced-solid-tumors-302677434.html

Feb 3, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next